Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margarita Sanchez-Del-Rio

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Journal of Headache and Pain|May 19, 2023
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysisChristian Lampl, Antoinette MaassenVanDenBrink, Christina I Deligianni, et al.
The Journal of Headache and Pain|July 23, 2024
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranololJan Versijpt, Christina Deligianni, Muizz Hussain, et al.
Nature Reviews. Neurology|July 12, 2023
The 5-HT<sub>1F</sub> receptor as the target of ditans in migraine - from bench to bedsideDimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, et al.
The Journal of Headache and Pain|September 18, 2023
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizineChristina I Deligianni, Simona Sacco, Esme Ekizoglu, et al.
The Journal of Headache and Pain|June 18, 2020
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)Simona Sacco, Mark Braschinsky, Anne Ducros, et al.
The Journal of Headache and Pain|April 10, 2023
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptylineChristian Lampl, Jan Versijpt, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain|October 9, 2023
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramateBianca Raffaelli, David García-Azorín, Deirdre M Boucherie, et al.
The Journal of Headache and Pain|May 19, 2021
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache AllianceSimona Sacco, Christian Lampl, Antoinette Maassen van den Brink, et al.
Neurology and Therapy|December 18, 2025
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment PlansPeter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, et al.
The Journal of Headache and Pain|June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 updateSimona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Headache and Pain|May 19, 2023
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysisChristian Lampl, Antoinette MaassenVanDenBrink, Christina I Deligianni, et al.
The Journal of Headache and Pain|July 23, 2024
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranololJan Versijpt, Christina Deligianni, Muizz Hussain, et al.
Nature Reviews. Neurology|July 12, 2023
The 5-HT<sub>1F</sub> receptor as the target of ditans in migraine - from bench to bedsideDimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, et al.
The Journal of Headache and Pain|September 18, 2023
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizineChristina I Deligianni, Simona Sacco, Esme Ekizoglu, et al.
The Journal of Headache and Pain|June 18, 2020
European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)Simona Sacco, Mark Braschinsky, Anne Ducros, et al.
The Journal of Headache and Pain|April 10, 2023
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptylineChristian Lampl, Jan Versijpt, Faisal Mohammad Amin, et al.
The Journal of Headache and Pain|October 9, 2023
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramateBianca Raffaelli, David García-Azorín, Deirdre M Boucherie, et al.
The Journal of Headache and Pain|May 19, 2021
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache AllianceSimona Sacco, Christian Lampl, Antoinette Maassen van den Brink, et al.
Neurology and Therapy|December 18, 2025
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment PlansPeter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, et al.
The Journal of Headache and Pain|June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 updateSimona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
Pageof 3